Amit Bhalodia, DO
Family Medicine · Camden, NJNPI 1982692083
Payments from drug & device makers
Across 463 payments — averaging $1526.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$608K
- Vertex$39K
- Boehringer Ingelheim International GmbH$31K
- Pfizer$25K
- AstraZeneca$655
- Sanofi-aventis U.S. LLC$635
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 79 | $607,572 |
| Vertex | 2 | $39,277 |
| Boehringer Ingelheim International GmbH | 150 | $30,688 |
| Pfizer | 21 | $24,829 |
| AstraZeneca | 31 | $655 |
| Sanofi-aventis U.S. LLC | 27 | $635 |
| AbbVie(2 entities) | 21 | $479 |
| Lilly USA, LLC | 26 | $367 |
| Bayer | 10 | $347 |
| GSK | 17 | $209 |
| Merck | 15 | $196 |
| Phathom Pharmaceuticals, Inc. | 6 | $175 |
| Exact Sciences | 8 | $171 |
| Biohaven Pharmaceuticals, Inc. | 1 | $164 |
| Novo Nordisk | 8 | $163 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $139 |
| Abbott | 4 | $83 |
| Novartis | 4 | $60 |
| Alkermes, Inc. | 3 | $45 |
| Amarin Pharma, Inc. | 3 | $41 |
| Astellas Pharma US Inc | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Hikma Pharmaceuticals USA | 2 | $27 |
| Amgen | 2 | $27 |
| Qiagen, LLC | 2 | $24 |
| Verona Pharma, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Strongbridge US Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| OPKO Pharmaceuticals, LLC | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $13 |
How this compares
$706,565 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Camden
- Christopher ColopintoCamden$20K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.